News

Cambridge Intellectual Property Training | 18 October 2018

Based in Cambridge and looking for insights into how to protect your IP, safeguard your ideas, innovation and creativity? James Pitchford will be presenting a training session at the Cambridge Information and Intellectual Property Meeting (CIIPM) in October Read more...

  • 21 Sep 2018

The European Medicines Agency pulls contracts with the UK’s MHRA

The European Medicines Agency (EMA) will no longer be allocating contracts to the UK's Medicines & Healthcare products Regulatory Agency (MHRA). Read commentary from Mathys & Squire Life Sciences Partner, Martin MacLean, here. Read more...

  • 13 Sep 2018

Innovation Showcase Competition - Venturefest North West 2018

Calling all entrepreneurs, start-ups and small to medium sized businesses. Venturefest North West is soon upon us and it's a great opportunity to learn more about developments and innovative ideas across product, service and digital fields. Read more...

  • 5 Sep 2018

An Innovation Conversation - A Q&A on Intellectual Property

Mathys & Squire Partner, Ilya Kazi, answers some FAQs on innovation and intellectual property. From protecting IP and encouraging innovation in both start-ups and big businesses to the effects of Brexit on IP and the evolution of the Chinese market - read his insights here. Read more...

  • 4 Sep 2018

Protecting the IP in your Software

How do you protect the intellectual property in your software? Here we are debunking a few myths around what is - and what isn't - eligible for patent protection. Click read more and to download a summary about software protection. Read more...

  • 3 Sep 2018

European Court Rules that Gene-Editing is Genetic Modification

On 25th July 2018, the Court of Justice of the European Union (CJEU) ended a decade-long debate on whether organisms obtained by gene-editing techniques should be treated as genetically modified organisms (GMOs) within the meaning of the GMO Directive… and the answer is “yes”. The upshot of this landmark ruling is that organisms obtained by modern gene-editing techniques, such as CRISPR/Cas9, must go through the same regulatory and approval process as organisms obtained using traditional transgenic methods. Read more...

  • 29 Aug 2018

Mathys & Squire EPO Opposition Hearing | California

Ever wondered what really happens in an EPO Opposition Hearing? Now is your chance to see from the comfort of The Hilton Garden Inn in Palo Alto! An afternoon of exemplary strategic case presentation from leaders in the legal field and live examiner feedback - click to RSVP. Read more...

  • 7 Aug 2018

A Digi-Addition to Cambridge

On 19th July 2018, the UK Government announced the establishment of a new Cambridge-based task force: the Digital Framework Task Group (DFTG), a team focused on harnessing the power of digital technologies to help UK industry plan for future construction needs. Read more...

  • 26 Jul 2018

Kit Kat Case Closed?

Kit Kat Case Closed? The European Court of Justice (ECJ) dismisses Nestlé's appeal and rules that the four-finger shape of its KitKat bar has not acquired distinctiveness across the entirety of the EU. Laura West explains... Read more...

  • 25 Jul 2018

Mathys & Squire at the Cambridge Information & Intellectual Property Meeting

On Wednesday July 11th, 2018, Mathys & Squire Partner, Jeremy Smith, attended the third annual Cambridge Information and Intellectual Property Meeting (information identifying a registration area) at Homerton College. Read more...

  • 23 Jul 2018